Red flags and when to proceed with caution Not every provider who prescribes GLP-1 medications does so responsibly
Hims is a telehealth service providing online consultations and prescription medications for weight loss, hair loss, sexual health, and more
The GLP-1 receptor agonists segment dominated the market with a share of 86% in 2025, as GLP-1 receptor agonists are driving historic market expansion by transforming obesity and diabetes management into a billion-dollar global industry
The letter went on to ask the FDA to increase enforcement over illegally imported obesity medications and other drugs by issuing warning letters, initiating civil enforcement actions and monitoring noncompliant online retailers and compounders selling unapproved [anti-obesity medications]. In a statement emailed to Healio, a spokesperson from HHS said, FDA is closely monitoring the compounding and distribution of GLP-1 drugs, including those marketed for weight loss
Consider these factors with your healthcare provider: How much do you need semaglutide